xlinked agammaglobulinemia xla rare genetic disorder discovered affects bodys ability fight infection form agammaglobulinemia xlinked much common males people xla white blood cell formation process generate mature b manifests complete nearcomplete lack proteins called gamma globulins including antibodies bloodstream b cells part immune system normally manufacture antibodies also called immunoglobulins defend body infections sustaining humoral immunity response patients untreated xla prone develop serious even fatal infections mutation occurs brutons tyrosine kinase btk gene leads severe block b cell development preb cell immature b cell stage reduced immunoglobulin production serum btk particularly responsible mediating b cell development maturation signaling effect b cell receptor bcr patients typically present early childhood recurrent infections particular extracellular encapsulated xla deemed relatively low incidence disease occurrence rate approximately live frequency male newborns ethnic predisposition xla treated infusion human antibody treatment pooled gamma globulin restore functional population b cells sufficient reduce severity number infections due passive immunity granted exogenous xla caused mutation x chromosome single gene identified produces enzyme known brutons tyrosine kinase xla first characterized dr ogden bruton groundbreaking research paper published describing boy unable develop immunities common childhood diseases first known immune deficiency classified inherited genetic defects immune system known primary immunodeficiency disorders affects males time mother carrier gene children generally asymptomatic months age maternal igg decreases present recurrent infections streptococcus pneumoniae haemophilus influenzae mycoplasma pneumoniae hepatitis virus enterovirus cns examination shows lymphoid hypoplasia tonsils adenoids splenomegaly lymphadenopathy significant decrease immunoglobulinscitation needed antibodies gamma globulins antibodies made mainly plasma cells daughter cells b cell line btk enzyme plays essential role maturation b cells bone marrow mutated immature prob lymphocytes unable develop preb lymphocytes normally develop mature naive b cells leave bone marrow blood streamcitation needed disorder inherited xlinked recessive fashion gene linked x chromosome almost entirely limited sons asymptomatic female males one copy x chromosome females two copies one normal copy x chromosome compensate mutations x chromosome less likely symptomaticcitation needed chance xla patients positive family history genetic inheritance rest cases occur random carrier female gives birth male child chance male xla carrier female chance overall giving birth affected male child xla patient pass gene daughters xla carriers meaning male grandchildren xla patients daughters chance inheriting xla female xla patient arise child xla patient carrier mother xla also rarely result spontaneous mutation fetus noncarrier mothercitation needed xla diagnosis usually begins due history recurrent infections mostly respiratory tract childhood due humoral diagnosis probable blood tests show complete lack circulating b cells determined b cell marker andor well low levels antibody classes including igg iga igm ige xla suspected possible western blot test determine whether btk protein expressed results genetic blood test confirm diagnosis identify specific btk however cost prohibits use routine screening pregnancies women xla patient family seek genetic counseling pregnancy although symptoms xla primary immune diseases pid include repeated often severe infections average time diagnosis pid yearscitation needed common treatment xla intravenous infusion immunoglobulin ivig human igg antibodies every week life ivig human product extracted pooled thousands blood donations ivig cure xla increases patients lifespan quality life generating passive immunity boosting immune treatment number severity infections reduced ivig xla patients may live relatively healthy life patient attempt reaching state igg blood count exceeds mgkg dose based patients weight igg bloodcountcitation needed muscle injections immunoglobulin imig common ivig prevalent less effective much painful hence imig uncommon subcutaneous treatment scig recently approved us food drug administration fda recommended cases severe adverse reactions ivig treatmentcitation needed antibiotics another common supplementary treatment local antibiotic treatment drops lotions preferred systemic treatment pills longterm treatment possible one future prospects xla treatment gene therapy could potentially cure xla gene therapy technology still infancy may cause severe complications cancer even death moreover longterm success complications treatment yet unknowncitation needed recommended dangerous xla patients receive live attenuated vaccines live polio measles mumps rubella mmr special emphasis given avoiding oral live attenuated sabintype polio vaccine reported cause polio xla patients furthermore known active vaccines general beneficial effect xla patients lack normal ability maintain immune memorycitation needed xla patients specifically susceptible viruses enterovirus family mostly polio virus coxsackie virus hand foot mouth disease echoviruses may cause severe central nervous system conditions chronic encephalitis meningitis death experimental antiviral agent pleconaril active picornaviruses xla patients however apparently immune epsteinbarr virus ebv lack mature b cells hla coreceptors needed viral patients xla also likely history septic known xla patients able generate allergic reaction lack functional ige antibodies special hazard xla patients dealing pets outdoor unlike primary immunodeficiencies xla patients greater risk developing autoimmune illnesses agammaglobulinemia xla similar primary immunodeficiency disorder hypogammaglobulinemia cvid clinical conditions treatment almost identical however xla congenital disorder known genetic causes cvid may occur adulthood causes yet understood addition xlinked agammaglobulinemia couple autosomal recessive agammaglobulinemia gene mutations described including mutations blnk deletion deletion terminal xla also historically mistaken severe combined immunodeficiency scid much severe immune deficiency bubble boysa strain laboratory mouse xid used study xla mice mutated version mouse btk gene exhibit similar yet milder immune deficiency xlacitation needed peripheral purine nucleoside phosphorylase deficiency httpsenwikipediaorgwikixlinkedagammaglobulinemia